We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA hit two online entities with warning letters after discovering they sold combination packs of unapproved abortion pills over the internet. Read More
Pfizer will pay $975,000 to settle allegations by the state of Oregon that the drugmaker distributed misleading coupons and marketing materials in the state. Read More
HHS Secretary Alex Azar defended the administration’s fiscal 2020 budget proposal before a House Appropriations Committee subcommittee hearing Wednesday, citing “difficult choices” but underscoring the administration’s commitment to containing drug prices and tackling the opioid crisis. Read More
House Democrats on Wednesday took testimony on their bid to reform America’s drug prices with a hearing on seven bills that seek to promote generics. Read More
A previous Avalere analysis found plans were increasingly placing generic drugs in non-generic tiers that require higher patient cost-sharing. Read More
The agency said it’s unnecessary to change the proper names of biological products that have already received licensing or approval and that lack an FDA-designated suffix. Read More
The FDA on Tuesday issued five guidance documents—including one final guidance—that the agency hopes will help sponsors get a handle on increasingly complex cancer trials. Read More
A federal court ordered Dallas, Texas-based drug compounder Guardian Pharmacy Services to suspend compounding activities, based on violations flagged by the FDA. Read More